Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 18% ± 3% | |
CD16-positive, CD56-dim natural killer cell, human | 6 studies | 19% ± 3% | |
natural killer cell | 6 studies | 18% ± 1% | |
retinal pigment epithelial cell | 5 studies | 58% ± 21% | |
non-classical monocyte | 3 studies | 23% ± 5% | |
glomerular endothelial cell | 3 studies | 22% ± 1% | |
regulatory T cell | 3 studies | 16% ± 1% | |
epithelial cell | 3 studies | 19% ± 3% | |
endothelial cell of artery | 3 studies | 21% ± 4% | |
gamma-delta T cell | 3 studies | 17% ± 2% |
Insufficient scRNA-seq data for expression of INPP5K at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2983.23 | 1445 / 1445 | 100% | 20.63 | 183 / 183 |
prostate | 100% | 3098.76 | 245 / 245 | 100% | 37.69 | 502 / 502 |
skin | 100% | 3459.82 | 1809 / 1809 | 100% | 40.22 | 472 / 472 |
thymus | 100% | 4987.56 | 653 / 653 | 100% | 60.36 | 605 / 605 |
uterus | 100% | 2763.14 | 170 / 170 | 100% | 22.77 | 459 / 459 |
kidney | 100% | 2202.49 | 89 / 89 | 100% | 29.01 | 900 / 901 |
lung | 100% | 4264.57 | 578 / 578 | 100% | 23.85 | 1152 / 1155 |
brain | 100% | 2120.58 | 2633 / 2642 | 100% | 37.86 | 705 / 705 |
ovary | 100% | 2475.88 | 180 / 180 | 100% | 17.88 | 428 / 430 |
bladder | 100% | 2764.29 | 21 / 21 | 99% | 23.84 | 501 / 504 |
breast | 100% | 4406.82 | 459 / 459 | 99% | 30.01 | 1111 / 1118 |
stomach | 100% | 2336.70 | 359 / 359 | 99% | 17.66 | 284 / 286 |
intestine | 100% | 2904.95 | 966 / 966 | 99% | 18.99 | 523 / 527 |
pancreas | 98% | 1445.11 | 323 / 328 | 100% | 24.13 | 178 / 178 |
adrenal gland | 100% | 2172.16 | 258 / 258 | 98% | 21.75 | 226 / 230 |
liver | 100% | 1208.89 | 225 / 226 | 98% | 13.28 | 398 / 406 |
adipose | 100% | 4899.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 56.19 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 36.86 | 29 / 29 |
muscle | 100% | 3279.23 | 803 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 3336.48 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 3526.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 28.27 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.98 | 1 / 1 |
blood vessel | 100% | 2969.43 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 2272.08 | 858 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045869 | Biological process | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
GO_0006469 | Biological process | negative regulation of protein kinase activity |
GO_0005979 | Biological process | regulation of glycogen biosynthetic process |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0001701 | Biological process | in utero embryonic development |
GO_0051926 | Biological process | negative regulation of calcium ion transport |
GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
GO_0043922 | Biological process | negative regulation by host of viral transcription |
GO_0032870 | Biological process | cellular response to hormone stimulus |
GO_0046856 | Biological process | phosphatidylinositol dephosphorylation |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0097178 | Biological process | ruffle assembly |
GO_0035305 | Biological process | negative regulation of dephosphorylation |
GO_2000466 | Biological process | negative regulation of glycogen (starch) synthase activity |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0010801 | Biological process | negative regulation of peptidyl-threonine phosphorylation |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0071320 | Biological process | cellular response to cAMP |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0090315 | Biological process | negative regulation of protein targeting to membrane |
GO_0016311 | Biological process | dephosphorylation |
GO_0010829 | Biological process | negative regulation of glucose transmembrane transport |
GO_0043407 | Biological process | negative regulation of MAP kinase activity |
GO_0033137 | Biological process | negative regulation of peptidyl-serine phosphorylation |
GO_0045719 | Biological process | negative regulation of glycogen biosynthetic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0035810 | Biological process | positive regulation of urine volume |
GO_2001153 | Biological process | positive regulation of renal water transport |
GO_0042593 | Biological process | glucose homeostasis |
GO_0051497 | Biological process | negative regulation of stress fiber assembly |
GO_0006661 | Biological process | phosphatidylinositol biosynthetic process |
GO_0001726 | Cellular component | ruffle |
GO_0032587 | Cellular component | ruffle membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0043005 | Cellular component | neuron projection |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0052658 | Molecular function | inositol-1,4,5-trisphosphate 5-phosphatase activity |
GO_0016312 | Molecular function | inositol bisphosphate phosphatase activity |
GO_0034485 | Molecular function | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity |
GO_0046030 | Molecular function | inositol trisphosphate phosphatase activity |
GO_0004439 | Molecular function | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity |
GO_0034595 | Molecular function | phosphatidylinositol phosphate 5-phosphatase activity |
GO_0034594 | Molecular function | phosphatidylinositol trisphosphate phosphatase activity |
GO_0005000 | Molecular function | vasopressin receptor activity |
GO_0052659 | Molecular function | inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity |
GO_0004445 | Molecular function | inositol-polyphosphate 5-phosphatase activity |
GO_0042577 | Molecular function | lipid phosphatase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | INPP5K |
Protein name | phosphoinositide 5-phosphatase (EC 3.1.3.36) Inositol polyphosphate-5-phosphatase K Inositol polyphosphate 5-phosphatase K (EC 3.1.3.56) (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.86) (Phosphatidylinositol-4,5-bisphosphate 5-phosphatase) (EC 3.1.3.36) (Skeletal muscle and kidney-enriched inositol phosphatase) inositol-polyphosphate 5-phosphatase (EC 3.1.3.56) |
Synonyms | PPS SKIP |
Description | FUNCTION: Inositol 5-phosphatase which acts on inositol 1,4,5-trisphosphate, inositol 1,3,4,5-tetrakisphosphate, phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate . Has 6-fold higher affinity for phosphatidylinositol 4,5-bisphosphate than for inositol 1,4,5-trisphosphate . Negatively regulates assembly of the actin cytoskeleton. Controls insulin-dependent glucose uptake among inositol 3,4,5-trisphosphate phosphatases; therefore, is the specific regulator for insulin signaling in skeletal muscle (By similarity). . |
Accessions | K7ENF7 ENST00000571274.5 I3L4A5 Q9BT40 ENST00000320345.10 [Q9BT40-2] ENST00000477910.5 ENST00000421807.7 [Q9BT40-1] ENST00000576646.7 K7EMS8 K7EPG6 ENST00000573790.5 ENST00000574955.1 ENST00000445774.2 I3L1R1 ENST00000406424.8 [Q9BT40-2] I3L0Y0 ENST00000350761.9 C9JZB0 ENST00000449479.5 ENST00000574561.1 ENST00000575172.5 C9JQW8 I3L2L1 I3NI31 ENST00000498390.5 J3KN07 |